Company Filing History:
2 out of 14 
2 out of 169 Years Active: 2016-2019
Title: **Ehud Shahar: Innovating Tumor Treatments**
Introduction
Ehud Shahar, a notable inventor based in Kiryat Shmona, Israel, has made significant contributions to the field of medical innovations. With two patents under his name, he is at the forefront of developing advanced treatment methodologies aimed at combating tumors through innovative approaches.
Latest Patents
Among his latest patents is the groundbreaking invention titled "Targeting of Innate Immune Response to Tumor Site." This invention introduces microparticles or nanoparticles designed specifically for tumor treatment. These particles consist of a targeting agent that binds to tumors or the surrounding environment, along with an inducer that enhances the immune response, ultimately leading to tumor apoptosis. The targeting agent is typically an antibody that recognizes specific antigens or receptors found on tumor cells. This approach not only shows promise in effectively targeting tumors but also represents a significant advancement in cancer treatment methodologies.
Career Highlights
Ehud Shahar has a rich professional background, having worked with prominent companies such as Gavish-Galilee Bio Applications Ltd. and Hadasit Medical Research Services and Development Ltd. His experience within these organizations has allowed him to hone his skills and focus on his innovative research in the medical field, particularly concerning cancer treatment technologies.
Collaborations
Throughout his career, Shahar has collaborated with talented individuals including Jacob Pitcovski and Raphael Gorodetsky. These collaborations have likely contributed to the richness of his ideas and the advancement of his inventions, fostering a dynamic environment for innovation.
Conclusion
Ehud Shahar’s work stands as a testament to the impact that innovative thinking can have on the medical field. His patents reflect a dedication to improving cancer treatment through targeted immune response technologies. As he continues to develop his research, the potential for his inventions to contribute significantly to the medical community grows ever larger.